Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/09/2025 ,inter alia, to consider and approve payment of interim dividend, if any, on Equity Shares of the Company for the financial year 2025-26.